Literature DB >> 10023689

p53 represses ribosomal gene transcription.

A Budde1, I Grummt.   

Abstract

Induction of the tumor suppressor protein p53 restricts cellular proliferation. Since actively growing cells require the ongoing synthesis of ribosomal RNA to sustain cellular biosynthesis, we studied the effect of p53 on ribosomal gene transcription by RNA polymerase I (Pol I). We have measured rDNA transcriptional activity in different cell lines which either lack or overexpress p53 and demonstrate that wild-type but not mutant p53 inhibits cellular pre-rRNA synthesis. Conversely, pre-rRNA levels are elevated both in cells which express mutant p53 and in fibroblasts from p53 knock-out mice. Transient transfection assays with a set of rDNA deletion mutants demonstrate that intergenic spacer sequences are dispensable and the minimal rDNA promoter is sufficient for p53-mediated repression of Pol I transcription. However, in a cell-free transcription system, recombinant p53 does not inhibit rDNA transcription, indicating that p53 does not directly interfere with the basal Pol I transcriptional machinery. Thus, repression of Pol I transcription by p53 may be a consequence of p53-induced growth arrest.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023689     DOI: 10.1038/sj.onc.1202402

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  69 in total

1.  TIF-IA, the factor mediating growth-dependent control of ribosomal RNA synthesis, is the mammalian homolog of yeast Rrn3p.

Authors:  J Bodem; G Dobreva; U Hoffmann-Rohrer; S Iben; H Zentgraf; H Delius; M Vingron; I Grummt
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

Review 2.  Survey and summary: transcription by RNA polymerases I and III.

Authors:  M R Paule; R J White
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 3.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  Overlapping functions of the pRb family in the regulation of rRNA synthesis.

Authors:  S Ciarmatori; P H Scott; J E Sutcliffe; A McLees; H M Alzuherri; J H Dannenberg; H te Riele; I Grummt; R Voit; R J White
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

5.  The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription.

Authors:  Yonggang Zhou; Raffaella Santoro; Ingrid Grummt
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

6.  The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Authors:  Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  The chromatin remodeling complex NoRC and TTF-I cooperate in the regulation of the mammalian rRNA genes in vivo.

Authors:  Attila Németh; Ralf Strohner; Ingrid Grummt; Gernot Längst
Journal:  Nucleic Acids Res       Date:  2004-08-03       Impact factor: 16.971

8.  Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis.

Authors:  Christopher D Castle; Erica K Cassimere; Jinho Lee; Catherine Denicourt
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

9.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

10.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.